Current evidence suggests that some people may be more susceptible to contracting an immune or inflammatory reaction when exposed to certain metals in implanted devices. Symptoms can be limited to the region where the device is or more generalized. Reported systemic symptoms include weakness, fatigue, rash and joint or muscle pain.
The FDA is hosting a meeting to discuss immune responses to metal-containing implants and dental amalgams Nov. 13-14, asking the public to determine crucial gaps in the current science and what FDA approaches should be considered.
More articles on dental:
HHS gives Florida health centers $4.6M for dental care
Nebraska dentists file complaint against state insurance department
Seniors prone to illness caused by poor oral hygiene
At the Becker's 5th Annual Future of Dentistry Roundtable, taking place September 14-15 in Chicago, dental leaders and executives will gain insights into emerging technologies, practice growth strategies and the evolving landscape of dental care delivery, with a focus on innovation, patient experience and operational excellence. Apply for complimentary registration now.
